Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001615219-16-000101
Filing Date
2016-01-25
Accepted
2016-01-25 11:47:42
Documents
1
Period of Report
2016-01-21

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_145374045136002.html 4  
1 FORM 4 wf-form4_145374045136002.xml 4 3968
  Complete submission text file 0001615219-16-000101.txt   5312
Mailing Address 15 SKYLINE DRIVE HAWTHORNE NY 10532
Business Address
Wessel Thomas (Reporting) CIK: 0001456055 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36812 | Film No.: 161357910

Mailing Address 800 BOYLSTON STREET 24TH FLOOR BOSTON MA 02199
Business Address 800 BOYLSTON STREET 24TH FLOOR BOSTON MA 02199 617-874-1821
Flex Pharma, Inc. (Issuer) CIK: 0001615219 (see all company filings)

EIN.: 465087339 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations